Concepedia
Statistics
Publications
31
Citations
1.6K
H-Index
21
Active since
1982
Affiliations
Institute of Cancer Research(Current)
Imperial College London
Cancer Research UK
University of Worcester
William Temple Foundation
John Reader is an author at Institute of Cancer Research specializing in organic chemistry, drug discovery, and chemistry.
Publications per year
1982–2021
Complex synthetic chemical libraries indexed with molecular tags.
Michael Ohlmeyer, R. N. Swanson, Lawrence W. Dillard et al. · Proceedings of the National Academy of Sciences · 1993 · 444 citations · Full text
Pharmacy, Biochemistry, Biotechnology +17
Gilbert Simondon: Being and Technology
John Reader · International Journal of Engineering Social Justice and Peace · 2013 · 120 citations · Full text
Social Sciences, Leadership, Sociology +11
The Preclinical Pharmacology and Therapeutic Activity of the Novel CHK1 Inhibitor SAR-020106
Michael I. Walton, Paul D. Eve, Angela Hayes et al. · Molecular Cancer Therapeutics · 2010 · 101 citations · Full text
Medicine, Oncology, Pharmacology +17
CCT244747 Is a Novel Potent and Selective CHK1 Inhibitor with Oral Efficacy Alone and in Combination with Genotoxic Anticancer Drugs
Mike I. Walton, Paul D. Eve, Angela Hayes et al. · Clinical Cancer Research · 2012 · 93 citations · Full text
Medicine, Oncology, Pharmacology +15
The clinical development candidate CCT245737 is an orally active CHK1 inhibitor with preclinical activity in RAS mutant NSCLC and Eμ-MYC driven B-cell lymphoma
Mike I. Walton, Paul D. Eve, Angela Hayes et al. · Oncotarget · 2015 · 69 citations · Full text
Medicine, Oncology, Pharmacology +14
1–5 of 31